Compare QNCX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | CHMI |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 108.3M |
| IPO Year | 2019 | 2013 |
| Metric | QNCX | CHMI |
|---|---|---|
| Price | $29.48 | $2.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 14.1K | ★ 249.2K |
| Earning Date | 04-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $61.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $2.17 |
| 52 Week High | $35.41 | $2.98 |
| Indicator | QNCX | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 48.26 | 49.42 |
| Support Level | $0.82 | $2.55 |
| Resistance Level | $35.38 | $2.98 |
| Average True Range (ATR) | 2.14 | 0.05 |
| MACD | -0.84 | -0.03 |
| Stochastic Oscillator | 34.79 | 13.89 |
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.